Johnson & Johnson: Spondylarthritis trials

The registry lists 15 Spondylarthritis studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 7 have results posted.

Early Phase 1 1Phase 3 6Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic ArthritisCompletedNCT03733925Phase 4Results posted
• A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial SpondyloarthritisTerminatedNCT02438787Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial SpondyloarthritisTerminatedNCT02437162Phase 3Results posted
• An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial SpondyloarthritisTerminatedNCT02407223Phase 3Results posted
• Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing SpondylitisCompletedNCT01248793Phase 3Results posted
• An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis ParticipantsCompletedNCT00760669Results posted
• A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing SpondylitisCompletedNCT00265083Phase 3Results posted
• A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDsCompletedNCT03131661
• An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip InvolvementTerminatedNCT02293681
• A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisWithdrawnNCT01692457
• Biologic Treatment Registry Across CanadaCompletedNCT00741793
• Post Marketing Surveillance of RemicadeCompletedNCT00724529
• Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and PsoriasisCompletedNCT00658827
• A Study to Test the Design, Functionality, and Ergonomic Features of the AutoinjectorCompletedNCT00643526Early Phase 1
• A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.CompletedNCT00207701Phase 3